StemCells completes acquisition of operating assets and businesses of SCS
StemCells, a biotechnology company, has completed the acquisition of substantially all of the operating assets and liabilities of Stem Cell Sciences, an international R&D company, for 2.65 million
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.